The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is 61.33 USD. With the latest stock price at 55.78 USD, the upside of Bristol-Myers Squibb Co based on DCF is 9.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.2% | 6.2% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 44.89 - 89.97 | 61.33 |
| Upside | -19.5% - 61.3% | 9.9% |